FDA NDC Directory · JSON-LD · Markdown

WEGOVY

NDC 0169-4415 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namesemaglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA218316
Dosage form / routeTABLET · ORAL
Active ingredientsSEMAGLUTIDE (1.5 mg/1)
Marketing started20260106
Package count2

External sources

Source: openFDA. Public-domain (CC0).